Last reviewed · How we verify
Benzylpenicillin - single dose
Benzylpenicillin - single dose is a Small molecule drug developed by Murdoch Childrens Research Institute. It is currently FDA-approved.
At a glance
| Generic name | Benzylpenicillin - single dose |
|---|---|
| Sponsor | Murdoch Childrens Research Institute |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial (PHASE2)
- Subcutaneous Piperacillin/Tazobactam Compared With Intravenous Treatment (PHASE2)
- Congenital Syphilis Treatment Trial (CONSISTENT) in Neonates (PHASE4)
- Comparative Efficacy of Antibiotics for Small Intestine Bacterial Overgrowth in Bangladeshi Children (PHASE2)
- Treatment Responses of Early Syphilis to Ceftriaxone Plus Doxycycline (PHASE4)
- Oral Antimicrobial Treatment vs. Outpatient Parenteral for Infective Endocarditis (PHASE4)
- PNEUmonia DOSing in Critically Ill Patients (PNEUDOS)
- Amoxicillin Alone Versus Amoxicillin/Clavulanate for Community-acquired Pneumonia in Patients Aged 65 Years or Older, and Hospitalized in a Non-intensive Care Unit Ward (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Benzylpenicillin - single dose CI brief — competitive landscape report
- Benzylpenicillin - single dose updates RSS · CI watch RSS
- Murdoch Childrens Research Institute portfolio CI
Frequently asked questions about Benzylpenicillin - single dose
What is Benzylpenicillin - single dose?
Benzylpenicillin - single dose is a Small molecule drug developed by Murdoch Childrens Research Institute.
Who makes Benzylpenicillin - single dose?
Benzylpenicillin - single dose is developed and marketed by Murdoch Childrens Research Institute (see full Murdoch Childrens Research Institute pipeline at /company/murdoch-childrens-research-institute).
What development phase is Benzylpenicillin - single dose in?
Benzylpenicillin - single dose is FDA-approved (marketed).